Children’s National Hospital is advancing new possibilities in pediatric brain tumor care through expanded focused ultrasound research using the NaviFUS neuronavigation-guided low-intensity focused ultrasound (LIFU) platform. The collaboration supports ongoing efforts to explore non-invasive therapeutic approaches for children with difficult-to-treat brain tumors.
Key Points：
-Researchers in Taiwan completed an early-stage trial showing focused ultrasound–mediated blood-brain barrier opening plus chemotherapy is safe in patients with GBM.
– The investigators are now recruiting participants for a larger clinical trial with the same device – the NaviFUS system – at two sites.
